Airway inflammation in patients affected by obstructive sleep apnea syndrome

Rubinstein, 1995, Nasal inflammation is present in patients with obstructive sleep apnea, Laringoscope, 105, 175, 10.1288/00005537-199502000-00012

Sekosan, 1996, Inflammation is present in the uvula mucosa of patients with obstructive sleep apnea, Laringoscope, 106, 1018, 10.1097/00005537-199608000-00021

Yin, 1995, Obstructive sleep apnea syndrome and bronchial hyperreactivity, Lung, 173, 117, 10.1007/BF02981471

Olopade, 1997, Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea, Chest, 111, 1500, 10.1378/chest.111.6.1500

Carpagnano, 2002, Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients, Chest, 122, 1162, 10.1378/chest.122.4.1162

Netzer, 1999, Using the Berlin Questionnaire to identify patients at risk for the sleep apnea sindrome, Ann Intern Med, 131, 485, 10.7326/0003-4819-131-7-199910050-00002

Spanevello, 2000, Induced sputum cellularity. Reference values and distribution in normal volunteers, Am J Respir Crit Care Med, 162, 1172, 10.1164/ajrccm.162.3.9908057

Zakkar, 1997, Decrease in immunoreactive neutral endopeptidase in uvula epithelium of patients with obstructive sleep apnea, Ann Otol Rhinol Laryngol, 106, 474, 10.1177/000348949710600606